Use of an intravenous contrast agent (Optison(TM)) to enhance echocardiography: Efficacy and cost implications

American Journal of Managed Care

Volumn 4, Issue SPEC. ISS. SEPT., 1998, Pages

  Shaw, Leslee J ^a   Gillam, Linda ^b   Feinstein, Steven ^c   Dent, John ^d   Plotnick, Gary ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARTFORD HOSPITAL   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDICARE; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

CARDIOMYOPATHIES; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; DRUG EVALUATION; ECHOCARDIOGRAPHY; HUMANS; INJECTIONS, INTRAVENOUS; LUNG DISEASES; MEDICARE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

EID: 7844251520     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Falcone RA, Marcovitz PA, Perez JE, Dittrich HC. Intravenous Albunex during dobutamine stress echocardiography: Enhanced localization of left ventricular endocardial borders. Am Heart J 1995;130:254-258.
2. Kaul S. Myocardial contrast echocardiography in coronary artery disease: Potential applications using venous injections of contrast. Am J Cardiol 1995;75:61D-68D.
3. Nihoynnopoulos P. Contrast echocardiography. Clin Radiol 1996;51(suppl 1):28-30.
4. Marwick TH. Recent advances in stress echocardiography. Curr Opin Cardiol 1995;10:619-625.
5. Hsiah A, Jollis JG, Kesler KL, et al. Prognostic value of transthoracic echo in the Duke Cardiovascular Disease Database. Circulation 1996;94:I-27. Abstract.
6. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-1424.
7. Shaw LJ, Eisenstein EL, Hachamovitch R, Heller GV, Miller DD, for the Economics of Noninvasive Diagnosis Multicenter Study. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. J Nucl Cardiol 1997;4:52-60.
8. Goldman L, Garber AM, Grover SA, Hlatky MA. Task force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-1030.
9. Hlatky MA, Lipscomb J, Nelson C, et al. Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. Circulation 1990;82(suppl IV):IV-208-IV-213.
10. Peterson ED, Jollis JG, DeLong ER, et al. National patterns of post-Ml noninvasive testing in the elderly: Results in 190,237 patients. Circulation 1996;94:I-507. Abstract.
11. Sonne HS, Christensen PD, Muan B, et al. Left ventricular opacification after intravenous injection of Albunex. Int J Card Imaging 1995;11:47-53.
12. Zotz RJ, Genth S, Waaler A, Erbel R, Meyer J. Left ventricular volume determination using Albunex. J Am Soc Echocardiogr 1996;9:1-8.
13. Kangarloo H, Ho BKT, Lufkin RB, et al. Effect of conversion from a fee-for-service plan to a capitation reimbursement system on a circumscribed outpatient radiology practice of 20,000 persons. Radiology 1996;201:79-84.
14. Porter TR, Xie F, Kricsfeld D, Armbruster RW. Improved myocardial contrast with second transient harmonic ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 1996;27:1497-1501.
15. Porter TR, Xie F, Anderson JR, Kricsfeld A, D'Sa A. Multifold sonicated dilutions of albumin with fifty percent dextrose improve left ventricular contrast videointensity after intravenous injection in human beings. J Am Soc Echocardiogr 1994;7:465-471.
16. Hundley WG, Kizilbash A, Afridi F, et al. Intravenous dodecafluoropentane improves determination of left ventricular function during transthoracic echocardiography. J Am Coll Cardiol 1997;29:520A. Abstract.
17. Enriquez-Sarano M, Wood DL, Tajik AJ, Schaff HV, Frye RL. Diagnostic tests utilization before mitral regurgitation surgery: A cost and outcome study. Circulation 1996;94:I-169. Abstract.